William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
Go back to William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)| (NASDAQ: TRDA) | Delayed: 7.45 -0.22 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.67 | 52 Week High | $ | |||
| Open | $7.74 | 52 Week Low | $ | |||
| Day High | $7.77 | P/E | N/A | |||
| Day Low | $7.37 | EPS | $ | |||
| Volume | 236,443 | |||||
